Led by London-based VC Concentric, with participation from Calm/Storm Ventures, GoHub, Kadmos, EWOR and Swiss super angel Daniel Gutenberg

由总部位于伦敦的风险投资公司Concentric领投，Calm/Storm Ventures、GoHub、Kadmos、EWOR以及瑞士超级天使投资人Daniel Gutenberg参与。

Aeon is building a new category of preventive health – combining AI, MRI scans, genetic and blood testing into a single platform for early detection and personalised risk prediction.

Aeon正在构建一个全新的预防健康类别——将人工智能、核磁共振成像、基因和血液检测结合到一个平台上，用于早期检测和个性化风险预测。

Offers the first full-body check up health scan eligible for insurance coverage

提供首次全身健康检查，符合保险覆盖条件

Plans to open 10+ new locations in the coming months

计划在未来几个月内开设10多家新店

Zurich, June 2025

苏黎世，2025年6月

– Swiss healthtech

瑞士健康科技

Aeon

永旺

has closed a €8.2 million seed round, as it builds the world’s most advanced platform for early detection and preventive healthcare. The round was led by London-based VC Concentric, with participation from Calm/Storm Ventures, GoHub Ventures, Kadmos Capital, EWOR, and Swiss super angel investor Daniel Gutenberg, known for backing 12 unicorns, including AirBnB, Facebook and SumUp..

已经完成了820万欧元的种子轮融资，致力于打造全球最先进的早期检测和预防性医疗平台。本轮融资由伦敦风险投资公司Concentric领投，Calm/Storm Ventures、GoHub Ventures、Kadmos Capital、EWOR以及瑞士超级天使投资人丹尼尔·古腾堡（Daniel Gutenberg）参投，他因支持包括AirBnB、Facebook和SumUp在内的12家独角兽企业而闻名。

While most consumer health platforms rely on surface-level data (like wearables, skin scans, or basic blood tests) Aeon integrates full-body MRI, advanced blood biomarkers, and genetic insights into a single 60-minute check-up. The result: early detection and prediction of over 500 diseases and health risks, reviewed by board-certified physicians and discussed directly with a radiologist.

大多数消费者健康平台依赖于表面数据（如可穿戴设备、皮肤扫描或基础血液检测），而Aeon将全身核磁共振成像、高级血液生物标志物和基因洞察整合到一个60分钟的体检中。结果：由委员会认证的医生审核，并与放射科医生直接讨论，实现对500多种疾病和健康风险的早期检测和预测。

To date, Aeon has maintained a 0% false positive rate in clinical-grade follow-ups, a critical differentiator in a field plagued by overdiagnosis and unnecessary procedures..

迄今为止，Aeon在临床级别的随访中保持了0%的假阳性率，这一关键区别在于一个饱受过度诊断和不必要程序困扰的领域。

Aeon uses AI in three ways:

Aeon以三种方式使用人工智能：

Automated imaging analysis: Detecting and quantifying anomalies on MRI scans, improving the speed and consistency of clinical evaluations

自动化影像分析：检测和量化MRI扫描中的异常，提高临床评估的速度和一致性。

Cross-validation: Correlating MRI, blood, and genetic data to reduce false positives and improve clinical relevance

交叉验证：关联MRI、血液和基因数据以减少假阳性并提高临床相关性

Predictive modeling: Generating a personalised risk profile for each user, forecasting the likelihood of over 500 conditions and enabling targeted prevention

预测建模：为每位用户生成个性化的风险档案，预测超过500种疾病的可能性，并实现针对性的预防措施。

According to the Global Alliance for Chronic Diseases, 41 million people die each year from non-communicable diseases (chronic illnesses that aren’t transmissible), a number projected to rise by 27% by 2030. Despite 80% of these deaths being preventable, fragmented data and sluggish healthcare systems continue to stand in the way of effective prevention..

根据全球慢性病联盟的数据，每年有4100万人死于非传染性疾病（不可传播的慢性疾病），预计到2030年，这一数字将上升27%。尽管其中80%的死亡是可以预防的，但碎片化的数据和迟缓的医疗系统仍在阻碍有效的预防措施。

Since launching in 2024, Aeon has already helped detect early-stage cancers, aneurysms, Alzheimer’s, and other critical conditions, often in people who felt perfectly healthy. In one case, a 56-year-old man with undiagnosed kidney cancer was identified through a single scan, enabling life-saving surgery..

自 2024 年推出以来，Aeon 已经帮助检测到早期癌症、动脉瘤、阿尔茨海默症和其他关键疾病，而这些往往发生在那些自认为完全健康的人身上。在其中一个案例中，一名 56 岁的未确诊肾癌男性通过一次扫描被识别出来，从而进行了挽救生命的手术。

It is also the first health platform to offer full-body check ups eligible for reimbursement by health insurers, and has already signed deals with Switzerland’s largest insurance providers, including KPT. Depending on the plan, customers can receive up to 80 percent of the cost back, setting a new precedent for accessible, proactive healthcare..

它也是首家提供可由健康保险公司报销的全身检查的健康平台，并且已经与瑞士最大的保险公司签订了协议，包括KPT。根据不同的保险计划，客户可以获得高达80%的费用返还，为便捷、积极的医疗保健树立了新的先例。

The new capital will support Aeon’s expansion across Switzerland, Germany, and the UK, with further international markets planned. It will also be used to accelerate partnerships with insurers and employers to improve access and affordability, and to enhance Aeon’s multi-modal AI platform for earlier and more precise diagnostics.

新资金将支持Aeon在瑞士、德国和英国的扩张，并计划进一步开拓国际市场。这笔资金还将用于加速与保险公司和雇主的合作，以提高可及性和可负担性，并加强Aeon的多模态人工智能平台，实现更早期、更精准的诊断。

Aeon plans to open more than 10 new locations in the coming months as it scales its clinical network..

永旺计划在未来几个月开设十多家新店，以扩大其临床网络的规模。

Aeon’s founding team includes CEO Tim Seithe, who previously founded and sold Tillhub to Unzer (KKR owned), and CPO Samuel Frey, who brings a decade of product leadership and most recently led a turnaround at diagnostics scale-up Platomics. They are joined by scientific advisor Dr. Andreas Lemke, one of Europe’s leading MRI physicists and founder of Mediaire, a company pioneering AI-driven brain imaging diagnostics..

Aeon的创始团队包括首席执行官蒂姆·赛瑟（Tim Seithe），他之前创立并将Tillhub出售给了Unzer（KKR旗下公司），以及首席产品官塞缪尔·弗雷（Samuel Frey），他拥有十年的产品领导经验，最近带领诊断初创公司Platomics实现了转型。他们还得到了科学顾问安德烈亚斯·勒姆克博士（Dr. Andreas Lemke）的支持，他是欧洲顶尖的核磁共振物理学家之一，同时也是开创性AI脑成像诊断公司Mediaire的创始人。

“We’re redefining preventive care by shifting it from reactive checks to proactive, personalised health management. Our approach goes beyond early disease detection — we’re tackling one of preventive medicine’s biggest challenges: false positives”,

“我们正在通过将预防性护理从被动检查转变为积极的、个性化的健康管理来重新定义它。我们的方法不仅仅是早期疾病检测——我们还在应对预防医学中最大的挑战之一：假阳性。”

said Tim Seithe, Aeon’s founder and CEO

Aeon的创始人兼首席执行官蒂姆·塞特说

. “Every customer receives a tailored risk profile, along with a clear, medically grounded plan to monitor and reduce their health risks over time.”

“每位客户都会获得一份定制的风险概况，以及一份清晰、基于医学的计划，以监测和降低他们的健康风险。”

“Aeon is not just another testing solution. In our view, many consumer health products on the market today deliver questionable value,”

“Aeon不仅仅是一个测试解决方案。我们认为，当今市场上的许多消费健康产品提供的价值值得怀疑。”

said Alex Stroud, Principal at Concentric

康瑟特公司负责人亚历克斯·斯特劳德说

. “Validated by insurers, Aeon is delivering the most medically robust preventive health product on the market. That rare combination of clinical rigor and commercial scalability is what makes this team so exciting.”

“经过保险公司验证，Aeon 提供了市场上医学上最强大的预防健康产品。临床严谨性和商业可扩展性这种罕见的结合正是这个团队如此令人兴奋的原因。”